Vinorelbine
Back to searchMolecule Structure
Scientific Name
Vinorelbine
Description of the Drug
Vinorelbine is a vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00361
http://www.drugbank.ca/drugs/DB00361
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Hospira Inc, Actavis Totowa Llc, Novast Laboratories Ltd, Ebewe Pharma Ges Mbh Nfg Kg, Pierre Fabre Medicament, Dr Reddys Laboratories Ltd, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095182 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4765 | ||
| DrugBank | DB00361 | ||
| PubChem: Thomson Pharma | 16335940 | ||
| PubChem | 5311497 | ||
| LINCS | LSM-6302 | ||
| EPA CompTox Dashboard | DTXSID8040640 | ||
| DrugCentral | 2827 | ||
| Metabolights | MTBLC480999 | ||
| Brenda | 127602 | ||
| ChemicalBook | CB3469220 | ||
| Guide to Pharmacology | 7105 | ||
| rxnorm | VINORELBINE | VINORELBINE TARTRATE | NAVELBINE |
| PubChem: Drugs of the Future | 12013497 | ||
| ChEBI | 480999 | ||
| ZINC | ZINC000085536958 |
